Riskpilot← Back to searchSign inGet full accessNERLIENS MESZANSKY AS
ASActiveOrg 914553695Nils Hansens Vei 8, 0667 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 191752 employeeswww.nmas.no
Revenue 2024
NOK 221M
-1% vs 2023
EBITDA margin
6.1%
+48% vs 2023
Equity ratio
30.4%
Financial strength
Net profit 2024
NOK 9,7M
+69% vs 2023
| Revenue | NOK 221M | -1% |
| EBITDA | NOK 13,4M | +48% |
| Net profit | NOK 9,7M | +69% |
| Total assets | NOK 96,7M | +2% |
| Equity | NOK 29,4M | -17% |
| Employees | 52 | — |
Legal name
NERLIENS MESZANSKY AS
Org number
914553695
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. mars 1917
Share capital
NOK 6 207 000
Employees
52 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Address
Nils Hansens Vei 8, 0667 Oslo
Website
www.nmas.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 307 763 | 450 470 | 255 260 | 223 056 | 221 012 |
| Staff expenses | −58 730 | −64 613 | −62 677 | −64 005 | −62 311 |
| EBITDA | 44 055 | 110 444 | 26 162 | 9 062 | 13 436 |
| Depreciation & amort. | −1 207 | −1 762 | −1 835 | −1 682 | −1 048 |
| EBIT | 42 849 | 108 682 | 24 327 | 7 380 | 12 388 |
| Net financials | 4 410 | 744 | −10 051 | −142 | −117 |
| Profit before tax | 47 258 | 109 427 | 14 277 | 7 238 | 12 271 |
| Tax | 9 523 | 23 438 | 5 601 | 1 495 | 2 538 |
| Net profit | 37 736 | 85 989 | 8 676 | 5 743 | 9 732 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 152 962 | 202 020 | 94 916 | 94 443 | 96 747 |
| Equity | 21 922 | 35 973 | 38 300 | 35 333 | 29 388 |
| Long-term debt | 350 | 0 | 0 | 0 | 0 |
| Short-term debt | 130 577 | 165 935 | 56 503 | 58 997 | 67 247 |
| Total debt | 130 927 | 165 935 | 56 503 | 58 997 | 67 247 |
EBITDA margin
6.1%
This company
15.8%
Market median
-61% vs market
20202024
Equity ratio
30.4%
This company
38.2%
Market median
+20% vs market
20202024
Return on equity
33.1%
This company
18.4%
Market median
+80% vs market
20202024
Net profit margin
4.4%
This company
8.1%
Market median
-46% vs market
20202024
Asset turnover
2.28×
This company
1.12×
Market median
+104% vs market
20202024
Debt / equity
2.29×
This company
0.62×
Market median
-269% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
ØL Deputy Member | Deputy Member | 2024 |
CR Deputy Member | Deputy Member | 2025 |
NN Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
SS Deputy Member | Deputy Member | 2023 – 2024 |
AJ Chief Executive Officer | Chief Executive Officer | 2003 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2019 | |
| Former (2) | ||
| Board of Directors | 2019 – 2024 | |
| Board of Directors | 2019 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vind As
NERLIENS MESZANSKY AS Board members of NERLIENS MESZANSKY AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Øyvind Løken | Deputy Member | 0 companies |
| Christine Rindal Ibra | Deputy Member | 0 companies |
| Nina Nielsen Bjerke | Chief Executive Officer | 0 companies |
| Sigurd Skålvoll Borgen | Deputy Member | 0 companies |
| Asbjørn Joar Jacobsen | Chief Executive Officer | 0 companies |
| Ghazal Rahmani Monfared Fogeby | Board of Directors | 0 companies |
| Joacim Rød Christiansen | Chairman | 0 companies |
| Christian Petersen | Board of Directors | 0 companies |
| Harald Høegh | Board of Directors | 0 companies |
| Morten Sandell | Board of Directors | 0 companies |
| Torsten Göran Brandt | Board of Directors | 0 companies |